93710-55-5

Usage

Chemical structure

The compound consists of a benzene ring with a bromino group (Br) at the 2-position and a methoxy group (OCH3) at the 6-position, with an acetonitrile functional group (CH3CN) attached to the 2-position.

Molecular weight

214.06 g/mol

Physical state

Solid

Appearance

Pale yellow or off-white crystalline solid

Solubility

Slightly soluble in water, soluble in common organic solvents such as ethanol, methanol, and acetone.

Melting point

94-96°C

Boiling point

Not readily available due to its stability as a solid; however, it can be expected to have a high boiling point due to the presence of the bromine atom.

Uses

Organic synthesis as a building block for various pharmaceuticals, agrochemicals, and materials; potential applications in the development of new drugs and as a precursor in the production of fine chemicals.

Properties

The presence of the bromino and methoxy substituents on the phenyl ring can potentially impart specific properties to the molecule, making it valuable in various research and industrial applications. The acetonitrile functional group imparts a polar character to the molecule, which can affect its reactivity and interactions with other molecules.

Upstream product

• 151-50-8 potassium cyanide 
• 93710-53-3 2-bromo-6-methoxybenzylchloride 
• 31786-45-5 2-bromo-6-methoxybenzoic acid 
• 93710-52-2 (2-bromo-6-methoxyphenyl)methanol 
• 55289-36-6 3-bromo-2-methylaniline 
• 7766-23-6 3-bromo-2-methylphenol 
• 773837-37-9 sodium cyanide 
• 126712-05-8 1-bromo-2-(bromomethyl)-3-methoxybenzene 
• 31804-36-1 1-bromo-3-methoxy-2-methylbenzene 
• 7677-24-9 trimethylsilyl cyanide 

Downstream Products

• 1329991-97-0 C₉H₁₀BrIO 
• 1329991-96-9 C₉H₁₁BrO₂ 
• 93710-62-4 N-(3-benzyloxy-4-methoxyphenethyl)-2-(2-bromo-6-methoxyphenyl)acetamide 
• 93710-63-5 N-(3-hydroxy-4-methoxyphenethyl)-2-(2-bromo-6-methoxyphenyl)acetamide 
• 93710-57-7 (2-bromo-6-methoxyphenyl)acetic acid 

Relevant academic research and scientific papers

SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER

Disclosed are compounds of Formula (I) or a salt thereof, wherein Ring A is a carbon-linked ring; and Ring A, R1, and n are defined herein. Also disclosed are methods of using such compounds to inhibit Helios protein, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

TETRAHYDROISOQUINOLINE DERIVATIVES

The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.

DERIVATIVES OF 1-PHENYL-1,5-DIHYDRO-BENZO[B] [1.4]DIAZEPINE-2.4-DIONE AS INHIBITORS OF HIV REPLICATION

Compounds of formula (I) wherein m, R1, R2, R3, X and Y are defined herein, are useful as inhibitors of HIV replication.

NEODIHYDROTHEBAINE AND BRACTAZONINE, TWO DIBENZAZONINE ALKALOIDS OF PAPAVER BRACTEATUM

Two new dibenzazonine alkaloids, neodihydrothebaine and bractazonine were isolated from Papaver bracteatum.Their possible biosynthesis from thebaine is discussed.The structures of both new alkaloids are proven by synthesis.An isomeric dibenzazonine compound was also prepared. - Keywords: Papaver bracteatum; Papaveraceae; alkaloids; dibenzazonines; neodihydrothebaine; bractazonine; biosynthetic pathway; synthesis; 5,6,8,9-tetrahydro-2-methoxy-7-methyl-dibenzazonin-1,12-diol; 5,6,8,9-tetrahydro-2,10-dimethoxy-7-methyl-dibenzazonin-1-ol; 5,6,8,9-tetrahydro-2,11-dimethoxy-7-methyl-dibenz-azonin-1-ol; 5,6,8,9-tetrahydro-2,12-dimethoxy-7-methyl-dibenzazonin-1-ol.